Gene: TRHDE
Official Full Name: thyrotropin releasing hormone degrading enzymeprovided by HGNC
Gene Summary: This gene encodes a member of the peptidase M1 family. The encoded protein is an extracellular peptidase that specifically cleaves and inactivates the neuropeptide thyrotropin-releasing hormone.[provided by RefSeq, Dec 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO26913 | TRHDE Knockout cell line (HCT 116) | Human | TRHDE | 1:2~1:4 | Negative | Online Inquiry |
TRHDE Gene Knockout Cell Lines are specialized cellular models created to precisely eliminate the expression of the TRHDE gene, which encodes the enzyme thyrotropin-releasing hormone-degrading enzyme. This process employs advanced CRISPR/Cas9 gene editing technology, enabling researchers to study the functional consequences of TRHDE gene disruption on various physiological and pathological processes, particularly those related to thyroid hormone regulation.
The key function of these knockout cell lines lies in their ability to facilitate the investigation of TRHDE's role in modulating levels of thyrotropin-releasing hormone (TRH) and subsequently influencing thyroid-stimulating hormone (TSH) secretion. Researchers can employ these cell lines to elucidate pathways involved in disorders characterized by dysregulation of the hypothalamic-pituitary-thyroid axis, including obesity, hypothyroidism, and certain neurodegenerative diseases. Furthermore, the TRHDE knockout model can help in the screening of therapeutic agents aimed at modulating TRH levels for potential clinical applications.
The scientific importance of TRHDE Gene Knockout Cell Lines is underscored by their potential applications in both basic and translational research settings. They represent a cutting-edge tool for drug discovery, biomarker identification, and functional genomics, providing a platform for comprehensive studies on therapeutic targets associated with thyroid hormone pathways.
Compared to traditional knockout models, which can be labor-intensive and time-consuming, our TRHDE Gene Knockout Cell Lines offer a streamlined, ready-to-use alternative that allows for quicker results and more efficient experimental workflows. The specificity and efficiency of CRISPR/Cas9 technology ensure a high degree of gene editing precision, promoting reproducible research outcomes.
By integrating these cell lines into their research or clinical practice, scientists and clinicians stand to gain significant insights into thyroid biology, providing a deeper understanding that may lead to novel therapeutic strategies for metabolic and hormonal disorders.
Our company is dedicated to providing high-quality biological products and cutting-edge gene editing tools, leveraging years of expertise in cellular and molecular biology to support the scientific community's pursuit of groundbreaking discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.